首页> 外文期刊>BioMed research international >Long Noncoding RNA H19 in Digestive System Cancers: A Meta-Analysis of Its Association with Pathological Features
【24h】

Long Noncoding RNA H19 in Digestive System Cancers: A Meta-Analysis of Its Association with Pathological Features

机译:在消化系统癌症中的长度非加入RNA H19:其与病理特征的关系的荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Long noncoding RNA (lncRNA) H19 has been reported to be upregulated in malignant digestive tumors, but its clinical relevance is not yet established. The meta-analysis was to investigate the association between H19 expression and pathological features of digestive system cancers. The databases of PubMed, EMBase, Web of Science, CNKI, and WanFang were searched for the related studies. A total of 478 patients from 6 studies were finally included. The meta-analysis showed that the patient group of high H19 expression had a higher risk of poorly differentiated grade, deep tumor invasion (T2 stage or more), lymph node metastasis, and advanced TNM stage than the group of low H19 expression, although there was no difference between them in terms of distant metastasis. Therefore, the high expression of lncRNA H19 might predict poor oncological outcomes of patients with digestive system cancers.
机译:据报道,据报道,长度非编码RNA(LNCRNA)H19在恶性消化肿瘤中升级,但尚未建立其临床相关性。 荟萃分析是探讨消化系统癌症的H19表达和病理特征之间的关联。 搜索了相关研究的PUBMED,EMBASE,科学网站,CNKI和WANFANG的数据库。 最后包括来自6项研究的478名患者。 荟萃分析表明,高H19表达的患者组具有较高的分化程度,深肿瘤侵袭(T2阶段或更多),淋巴结转移和高级TNM阶段的风险较高,而不是低H19表达,尽管在那里 在远处转移方面没有区别。 因此,LNCRNA H19的高表达可能预测消化系统癌症患者的疾病性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号